Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial.
Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial.
复制标题
补充胆钙化醇不会影响开始抗逆转录病毒治疗的坦桑尼亚成年人的艾滋病毒进展、病毒抑制、合并症、体重减轻和抑郁的风险：随机试验的次要结果。
DOI：
10.1093/jn/nxac096
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Sudfeld,ChristopherR
中科院分区：
文献类型：
--
作者：
Muhihi,Alfa;Fawzi,WafaieW;Aboud,Said;Nagu,TumainiJ;Ulenga,Nzovu;Wang,Molin;Mugusi,Ferdinand;Sudfeld,ChristopherR
